Rindz Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 29-12-2024
- Paid Up Capital ₹ 1.00 M
as on 29-12-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.30 M
as on 29-12-2024
- Revenue 7.79%
(FY 2021)
- Profit 44.23%
(FY 2021)
- Ebitda -21.12%
(FY 2021)
- Net Worth 4.05%
(FY 2021)
- Total Assets -5.94%
(FY 2021)
About Rindz Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.30 M.
Shanmugam Rajeswaran, Narmadha, and Rajeswaran Gowri serve as directors at the Company.
- CIN/LLPIN
U51909TN2018PTC123985
- Company No.
123985
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 2018
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rindz Pharma Private Limited offer?
Rindz Pharma Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Digestive System Drugs & Medicines, Digestive Drugs, Nutraceuticals & Dietary Supplements, Mineral Supplement, Bird Food, Poultry & Animal Food, Animal Feed Supplement.
Who are the key members and board of directors at Rindz Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shanmugam Rajeswaran  | Director | 06-Aug-2018 | Current |
| Narmadha | Director | 13-Jun-2019 | Current |
| Rajeswaran Gowri | Director | 06-Aug-2018 | Current |
Financial Performance of Rindz Pharma.
Rindz Pharma Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 7.79% increase. The company also saw a substantial improvement in profitability, with a 44.23% increase in profit. The company's net worth moved up by a moderate rise of 4.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rindz Pharma?
In 2021, Rindz Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maximus Healthcare Private LimitedActive 11 years 10 monthsShanmugam Rajeswaran and Rajeswaran Gowri are mutual person
Charges (Loans)
₹5.30 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.30 Cr
- Hdfc Bank Limited : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Feb 2024 | Indian Bank | ₹2.95 M | Open |
| 25 Jul 2023 | Hdfc Bank Limited | ₹2.35 M | Open |
How Many Employees Work at Rindz Pharma?
Rindz Pharma has a workforce of 12 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rindz Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rindz Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.